Can the continuous outbreak of the big consumption sector serve as the main line of the New Year? Can the continuous outbreak of the big consumer sector serve as the main line of the New Year? In this regard, Zhang Cuixia, the chief investment consultant of Jufeng Investment and the chief tutor and general manager of the investment and education division, believes that it is recommended to cash in before the year and operate according to the big-band thinking; Lin Longpeng, chief market analyst of Guotai Junan Securities Research Institute, believes that the big consumer sector is expected to have trading opportunities; Zhu Qi of Galaxy Securities believes that the follow-up policy support of the large consumer sector is expected to be strong, and the segmentation sector is bullish. (CBN)Barclays lowered its target share price of Nike from $81 to $79.Runyang's Jianhu 16GW N high-efficiency solar cell base resumed production. According to Runyang's WeChat WeChat official account news, on December 9, Runyang's Jianhu 16GW N high-efficiency solar cell base officially resumed production, which is another advanced solar cell base of Runyang in China since it resumed production in Qujing, Yunnan in October this year. It is reported that Runyang Jianhu production base is the largest single N-type battery production base in China at present, which has achieved full coverage of intelligent production and has an annual production capacity of 16GW of solar cells, and is committed to becoming one of the largest and most technologically advanced high-efficiency photovoltaic cell production bases in the world.
The main contract of the container transport index (European line) fell more than 4.00% in the day and is now reported at 2436.2 points.Bain raised its offer for Fuji Software to 9,600 yen per share.A number of private placements are optimistic about the market at the end of the year, and the two major directions are favored. Recently, A-shares have fluctuated, and the latest strategies of a number of first-line private placements for investment at the end of the year and the beginning of the year have been released one after another. A number of private placements are optimistic about the market at the end of the year. Kou Zhiwei, a partner of chongyang investment, said that the "strengthening unconventional countercyclical adjustment" proposed by the policy at the end of the year inspired market confidence. At present, compared with the end of September, the market has a large increase, and the market has fully expected and priced the policy overweight. The further rise of the short-term market may need the support of strong economic recovery data. Lei, deputy general manager and chief strategic investment official of Xingshi Investment, said that the current positive factors in the stock market are still accumulating, and the fundamentals, policies and funds are all supported. Judging from the recent overall investment trends of private placement, the reporter found that maintaining medium and high positions and maintaining high flexibility of portfolios have become the strategic focus of current private placement institutions. Judging from the specific optimistic investment direction at the end of the year, according to the comprehensive interview with private equity, consumption and technology are relatively more popular at present. (CSI Taurus)
The global layout will further promote Sannuo Bio-CGM products to enter the European market. Recently, Sannuo Bio-CGM has reached a strategic cooperation with A.Menarini Diagnostics, a leading European medical diagnosis company, and signed an exclusive distribution agreement. The continuous glucose monitoring (CGM) products of Sannuo Bio will be launched in the European market in the form of joint brands of both parties. Sannuo Bio authorized A.Menarini Diagnostics to exclusively sell its CGM products in more than 20 countries and regions in Europe. In the future, the latter will vigorously promote the access, promotion and sales of Sannuo Bio CGM products in the European medical insurance market. Sannuo Bio has been actively deploying its internationalization strategy since its listing, and its iCan CGM is the first continuous glucose monitoring product certified by CE MDR in China. At present, Europe is the second largest market for CGM. In this cooperation, the two sides signed an exclusive distribution contract with considerable volume, which is expected to greatly accelerate the penetration and coverage of Sannuo Bio-CGM products in the European market.Wang Tao, UBS: It is expected that the Central Economic Work Conference will focus on the short-term policy package. Recently, the market highly expects the Central Economic Work Conference to guide the high-quality economic development of China next year. Wang Tao, head of Asian economic research at UBS and chief China economist, said: "I expect that the Central Economic Work Conference may focus on the short-term policy package in 2025 and 2026, but it will also emphasize accelerating some reform measures already outlined at the Third Plenary Session." Wang Tao believes that the next important reform measures may include providing better protection and access for the private economy, deepening the reform of state-owned enterprises to improve efficiency and governance, promoting household registration reform to improve the welfare of migrant workers, strengthening the social security network, and carrying out fiscal and taxation reforms to solve local fiscal revenue problems. "I think structural, deeper and faster reforms will be very important, not only to attract foreign investment, but also to boost domestic confidence." (China Daily)Chen Honghui, director of the Health and Health Commission of Hubei Province, is the new deputy secretary of Yichang Municipal Committee. According to the Three Gorges Daily in Yichang, Hubei Province, on December 10th, Yichang held a meeting of leading cadres in the whole city, and the organization department of Hubei Provincial Committee announced that Chen Honghui was appointed as a member, standing committee member and deputy secretary of CPC Yichang Municipal Committee. Previously, Chen Honghui served as Party Secretary and Director of Hubei Provincial Health and Wellness Committee.
Strategy guide 12-13
Strategy guide
12-13
Strategy guide
12-13